StockData

Caribou Biosciences vs Relay Therapeutics

CRBU and RLAY side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CRBU and RLAY compare

Relay Therapeutics is the larger company, worth 99 times as much as Caribou Biosciences ($3.6B against $36.5M).

Relay Therapeutics grew revenue faster over the last twelve months (23.9% versus 10.0% for Caribou Biosciences).

Caribou Biosciences keeps more of each dollar of sales as profit, with a net margin of −1030% compared with −2764% at Relay Therapeutics.

Relay Therapeutics scores higher on the StockData Score (10 against 9 for Caribou Biosciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCRBURLAY
Size and price
Market cap$36.5M$3.6B
Share price$0.341$16.47
Change, 1 year−82.9%162%
Change, 5 years−98.1%−44.8%
Beta (5Y)1.411.96
Employees97192
StockData Score
Total score910 (better)
Valuation score3 (better)0
Growth score12 (better)
Performance score02 (better)
Health score56 (better)
Dividend score00
Valuation
P/S3.6× (better)349×
P/B0.4× (better)4.1×
FCF yield−262%–
Fair value$1.29–
Margin of safety73.7%–
Growth
Revenue growth (TTM)10.0%23.9% (better)
Revenue growth, 5Y average−2.0% (better)−28.6%
Profitability
Operating margin−1091% (better)−2999%
Net margin−1030% (better)−2764%
FCF margin−954%–
Return on equity−78.3%−36.8% (better)
Return on invested capital–−37.1%
Financial health
Debt / equity0.000.00
Current ratio6.4918.27 (better)
Altman Z-score−7.4724.86 (better)
Piotroski F-score24 (better)
Dividends and buybacks
Buyback yield−66.3%–
Shareholder yield−66.3%0.00% (better)
Ownership
Held by institutions45.5%113%
Held by insiders5.7%24.5%
Insider net buying, 12 months−$47.5K (better)−$129M
Superinvestors holding–1
Short interest, % of float14.7%26.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.